<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[Prescription Drug Industry: Market Research Reports, Statistics and Analysis]]></title>
    <link>http://www.reportlinker.com/ci02264/Prescription-Drug.html</link>
    <description><![CDATA[Reportlinker.com Lastest Prescription Drug Industry: Market Research Reports, Statistics and Analysis]]></description>
    <pubDate>Wed, 19 Jun 2013 13:06:42 +0000</pubDate>
    <webMaster>helpdesk@reportlinker.com</webMaster>
    <copyright>Copyright 2013, Reportlinker</copyright>
    <generator>Zend_Feed</generator>
    <language>en-us</language>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <item>
      <title><![CDATA[Prescription Drug Production and Trade Statistics in The United States]]></title>
      <link>http://www.reportlinker.com/d014374510/Prescription-Drug-Production-and-Trade-Statistics-in-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014374510/Prescription-Drug-Production-and-Trade-Statistics-in-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... <Strong>prescription</strong> <strong>drugs</strong>, to 3 the extent such pharmacy, group, or person 4 does not act as a wholesale distributor; 5 (b) includes warehouses and distribution 6 centers under common ownership or control of 7 ...]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Prescription Drug Production and Trade Statistics in The United States]]></title>
      <link>http://www.reportlinker.com/d014338285/Prescription-Drug-Production-and-Trade-Statistics-in-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014338285/Prescription-Drug-Production-and-Trade-Statistics-in-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Prescription Drug Market Trends]]></title>
      <link>http://www.reportlinker.com/d014346717/Prescription-Drug-Market-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014346717/Prescription-Drug-Market-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... To the discussion draft since the hearing. Most notably, the  updated discussion draft contains two important changes to address concerns from some of my  colleagues. First, it ensures that a <strong>prescription</strong> <strong>drug</strong> ...]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[U.S. Prescription Drug Industry Analysis]]></title>
      <link>http://www.reportlinker.com/d014229117/U-S-Prescription-Drug-Industry-Analysis.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014229117/U-S-Prescription-Drug-Industry-Analysis.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_ppt_small.gif" width="65px" height="80px"> ... Key terminology   <Strong>prescription</strong> <strong>drug</strong> plan (pdp)-insurance plan used  to cover <strong>prescription</strong> <strong>drugs</strong> as part of medicare part d   Doughnut hole-point at which pdp stops offering  coverage ...]]></description>
      <pubDate>Sun, 31 Mar 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[U.S. Prescription Drug Industry : Production and Trade Statistics]]></title>
      <link>http://www.reportlinker.com/d014365665/U-S-Prescription-Drug-Industry-Production-and-Trade-Statistics.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014365665/U-S-Prescription-Drug-Industry-Production-and-Trade-Statistics.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Tus the medical convenience kit 9 does not alter the primary container 10 or label of the <strong>prescription</strong> <strong>drug</strong> prod-11 uct as purchased from the manufac-12 tu or wholesale distributor; 13 (iv ...]]></description>
      <pubDate>Sun, 31 Mar 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Company Report: Prescription Drug in The United States for Year 2013]]></title>
      <link>http://www.reportlinker.com/d014297351/Company-Report-Prescription-Drug-in-The-United-States-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014297351/Company-Report-Prescription-Drug-in-The-United-States-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... A novel approach to the management of certain  disease states, focusing on safety and efficacy without the deleterious side effects of trional, high dose  <strong>prescription</strong> <strong>drugs</strong>.  The company is developing ...]]></description>
      <pubDate>Sun, 31 Mar 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Company Report: Prescription Drug for Year 2013]]></title>
      <link>http://www.reportlinker.com/d014351708/Company-Report-Prescription-Drug-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014351708/Company-Report-Prescription-Drug-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Benefits program.  Your company likely spends a significant amount of money on <strong>prescription</strong> <strong>drugs</strong> through the  pharmacy benefits you offer. But, it S much more than a financial investment. <Strong>prescription</strong> <strong>drugs</strong> ...]]></description>
      <pubDate>Sun, 31 Mar 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Walgreen Co. - Company Report for Year 2013]]></title>
      <link>http://www.reportlinker.com/d014238104/Walgreen-Co-Company-Report-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014238104/Walgreen-Co-Company-Report-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ]]></description>
      <pubDate>Thu, 28 Feb 2013 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Company Report: Prescription Drug in The United States for Year 2013]]></title>
      <link>http://www.reportlinker.com/d014343970/Company-Report-Prescription-Drug-in-The-United-States-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014343970/Company-Report-Prescription-Drug-in-The-United-States-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ]]></description>
      <pubDate>Thu, 28 Feb 2013 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Oliver Wyman - Company Report for Year 2013]]></title>
      <link>http://www.reportlinker.com/d014337431/Oliver-Wyman-Company-Report-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014337431/Oliver-Wyman-Company-Report-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Equal to 0.1%. This is significantly lower than the low end of the  ow recommended range for <strong>prescription</strong> <strong>drug</strong> trend, as described in the 3q13-4q13 epo/ppo  small group filing, which is 8 ...]]></description>
      <pubDate>Thu, 28 Feb 2013 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Prescription Drugs Markets in China]]></title>
      <link>http://www.reportlinker.com/p01163546/Prescription-Drugs-Markets-in-China.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01163546/Prescription-Drugs-Markets-in-China.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/70.gif"> China's demand for prescription drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, ...]]></description>
      <pubDate>Sun, 14 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Bulgaria Pharmaceuticals and Healthcare Industry Update Quarter 2 2012]]></title>
      <link>http://www.reportlinker.com/p0181211/Bulgaria-Pharmaceuticals-and-Healthcare-Report-Q2.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0181211/Bulgaria-Pharmaceuticals-and-Healthcare-Report-Q2.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1322.gif"> BMI View: Bulgaria's pharmaceutical industry will be under some pressure in 2012 due to a weakening economic outlook and the tightening of publicly funded healthcare services. However, we have broadly ...]]></description>
      <pubDate>Tue, 09 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Taiwan Pharmaceuticals and Healthcare Industry Update Quarter 3 2012]]></title>
      <link>http://www.reportlinker.com/p0203576/Taiwan-Pharmaceuticals-and-Healthcare-Report-Q3.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0203576/Taiwan-Pharmaceuticals-and-Healthcare-Report-Q3.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1322.gif"> Includes 3 FREE quarterly updates  BMI View: We do not expect Taiwan's healthcare expenditure to reach the government's target of 7.5% of Gross Domestic Product in the short to medium term - unless it ...]]></description>
      <pubDate>Tue, 21 May 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Portugal Business Projection Industry Update Quarter 2 2012]]></title>
      <link>http://www.reportlinker.com/p0840302/Portugal-Business-Forecast-Report-Q2.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0840302/Portugal-Business-Forecast-Report-Q2.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1322.gif"> Includes 3 FREE quarterly updates Core Views Portugal is in the midst of a deep recession that will last until at least 2013. We do not see substantially higher growth beyond this. We are expecting contractions ...]]></description>
      <pubDate>Wed, 03 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Axxess Pharma, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile]]></title>
      <link>http://www.reportlinker.com/p0844992/Axxess-Pharma-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0844992/Axxess-Pharma-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1357.gif"> Summary Axxess Pharma, Inc. is engaged in commercialization of dermatological, therapeutic nutritionals, pain management and diagnostic products. The company is headquartered in Ontario, Canada. Axxess ...]]></description>
      <pubDate>Sun, 28 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Heritage Pharmaceuticals Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile]]></title>
      <link>http://www.reportlinker.com/p0466772/Heritage-Pharmaceuticals-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0466772/Heritage-Pharmaceuticals-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1357.gif"> Summary Heritage Pharmaceuticals Inc. (Heritage) is a pharmaceutical company, based in the US. The company acquires licenses, develops and commercializes generic pharmaceutical products for worldwide prescription ...]]></description>
      <pubDate>Tue, 14 May 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Jade Pharmaceuticals Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile]]></title>
      <link>http://www.reportlinker.com/p01097300/Jade-Pharmaceuticals-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01097300/Jade-Pharmaceuticals-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1357.gif"> Summary Jade Pharmaceutical Inc. (Jade) is a biopharma company, engaged in the development, manufacture and marketing of proprietary pharmaceutical and diagnostic products. It owns two GMP certified pharmaceutical ...]]></description>
      <pubDate>Thu, 16 May 2013 22:00:00 +0000</pubDate>
    </item>
  </channel>
</rss>
